REFERENCES
- Kane J, Honigfeld G, Singer J, Meltzer H, et al.: Clozapine for the treatment-resistant schizophrenic. Arch Gen Psychia-try 1988; 45:789–796
- Baldessarini RI, Frankenburg FR. Clozapine—A novel antip-sychotic agent. N Engl J Med 1991; 325:746–754
- Frankenburg FR, Zanarini MC. The uses of clozapine in non-schizophrenic patients. Harvard Rev Psychiatry 1994; 2:142–150
- Alvir JMJ, Lieberman JA, Safferman AZ, Schwimmer JL, et at.: Clozapine-induced agranulocytosis. Incidence and risk fac-tors in the United States. N Engl J Med 1993; 329:162–167
- Stricker BHC, Tielen JAE. Eosinophilia with clozapine. Lan-cet 1991; 338:1520–1521
- Banov MD, Tohen M, Friedberg J. High risk of eosinophilia in women treated with clozapine. J Clin Psychiatry 1993; 54:466–469
- Frankenburg FR, Kando J. Eosinophilia, clozapine, and pan-creatitis. Lancet 1992; 340:251
- Harvey RJ, Bullock T, Montgomery SA. Diarrhea during treatment with clozapine: association with lymphocyte count. Br Med J 1992; 305: 810
- Patterson BD, Jennings JL. Spiking fever and profuse diar-rhea with clozapine treatment. Am J Psychiatry 1993; 150:1126
- Druss BG, Mazure CM. Transient fever and hematologic ab-normalities during clozapine use. J Clin Psychopharmacol 1993; 13:155–156
- Nayor AR, Pollet JE. Eosinophilic colitis. Dis Colon Rectum 1985; 28:615–618
- Blacicshaw AJ, Levison DA. Eosinophilic infiltrates of the gas-trointestinal tract. J Clin Pathol 1986; 39:1–7
- Anttila V-J, Valtonen M. Carbamazepine-induced eosinophilic colitis. Epilepsia 1992; 33:119–121
- Martin DM, Goldman JA, Gilliam J, Nasrallah SM. Gold-in-duced eosinophilic enterocolitis: Response to oral cromolyn sodium. Gastroenterology 1981; 80:1567–1570
- Bridges AJ, Marshall JB, Diaz-Arias AA. Acute eosinophilic colitis and hypersensitivity reaction associated with naproxen therapy. Am J Med 1990; 89:526–527